Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients
NCT00745407 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2008-09-03
Summary
Fenofibrate increases adiponectin levels, but reduces leptin levels
Conditions
- Hypertriglyceridemia
Interventions
- DRUG
-
fenofibrate
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Study Design
- Purpose
- TREATMENT
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2008-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Effectiveness of a Weight Management Programme on Diabetes Remission in Obese Patients With Early Diabetes
NCT05762120 ·Status: UNKNOWN ·Phase: NA
-
Short-term Fat Overfeeding on the Effects of Liver Metabolism
NCT05962190 ·Status: RECRUITING ·Phase: NA
-
Effect of Diet Composition on Liver Fat and Glucose Metabolism
NCT00930371 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects
NCT01778257 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Phenotyping for Personalized Obesity Therapy
NCT06874270 ·Status: RECRUITING
-
Weight Loss for a Healthier You Programme
NCT05049954 ·Status: UNKNOWN ·Phase: NA
-
Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
NCT05645913 ·Status: UNKNOWN
-
Pharmacological Activation of Brown Adipose Tissue Metabolism
NCT02811289 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797 ·Status: COMPLETED
-
Leptin in the Maintenance of Reduced Body Weight
NCT01155180 ·Status: COMPLETED ·Phase: PHASE2
-
Leptin Biology in Adipose Tissue
NCT01800864 ·Status: COMPLETED ·Phase: NA
-
Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise
NCT01260376 ·Status: COMPLETED ·Phase: NA
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
The Impact of High-Fat Ketogenic Diet and Low-Fat Diet in Women Body Weight
NCT05811702 ·Status: UNKNOWN ·Phase: NA
-
Diet Impact on Hepatic Transcriptomics and Lipidomics in Pre-diabetes
NCT05965973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167 ·Status: ENROLLING_BY_INVITATION
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
Effects of Fat and Carbohydrates in Obese Men
NCT01750021 ·Status: COMPLETED ·Phase: NA
-
Metabolically Normal and Metabolically Abnormal Obesity
NCT01184170 ·Status: COMPLETED ·Phase: NA
-
Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
NCT05685017 ·Status: COMPLETED
-
Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity
NCT01138774 ·Status: COMPLETED ·Phase: NA
-
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
NCT05106049 ·Status: UNKNOWN
-
Fetal Programming of Obesity
NCT01131117 ·Status: COMPLETED
-
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008 ·Status: COMPLETED
-
Serum ANGPTL3, ANGPTL8 and Glypican 4 Concentrations in Relation to the Development of Obesity in Korean Children
NCT02389556 ·Status: COMPLETED